Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$22.3 - $37.39 $1.32 Million - $2.21 Million
-59,113 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$25.68 - $35.59 $3.5 Million - $4.85 Million
-136,253 Reduced 69.74%
59,113 $2.05 Million
Q4 2021

Feb 14, 2022

SELL
$24.9 - $40.26 $5.56 Million - $8.99 Million
-223,197 Reduced 53.32%
195,366 $5.72 Million
Q3 2021

Nov 15, 2021

BUY
$25.48 - $37.34 $1.92 Million - $2.81 Million
75,387 Added 21.97%
418,563 $10.7 Million
Q2 2021

Aug 16, 2021

BUY
$32.46 - $43.42 $1.89 Million - $2.53 Million
58,221 Added 20.43%
343,176 $12 Million
Q1 2021

May 17, 2021

SELL
$38.94 - $50.85 $2.21 Million - $2.88 Million
-56,628 Reduced 16.58%
284,955 $11.6 Million
Q4 2020

Feb 16, 2021

BUY
$37.65 - $63.77 $11.7 Million - $19.9 Million
311,657 Added 1041.43%
341,583 $14.8 Million
Q3 2020

Nov 16, 2020

BUY
$52.76 - $74.49 $1.58 Million - $2.23 Million
29,926 New
29,926 $1.65 Million
Q1 2020

May 15, 2020

SELL
$41.72 - $87.2 $1.6 Million - $3.35 Million
-38,423 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$45.7 - $81.86 $1.76 Million - $3.15 Million
38,423 New
38,423 $3.05 Million
Q2 2018

Aug 14, 2018

SELL
$38.7 - $50.15 $1.5 Million - $1.95 Million
-38,806 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$39.6 - $65.9 $1.54 Million - $2.56 Million
38,806 New
38,806 $1.87 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.